Back to search
Xeroderma Pigmentosum
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Xeroderma Pigmentosum trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Xeroderma Pigmentosum trials you may qualify forThe purpose of this study is to evaluate the Safety and Efficacy of Gene Therapy of the severe combined immunodeficiency (SCID) caused by mutations in the human…
This will be a single-center, single-arm, non-interventional natural history study to evaluate the longitudinal clinical course, functional outcome measures, an…
Four rare genetic diseases, xeroderma pigmentosum (XP), Cockayne syndrome (CS), the XP/CS complex and trichothiodystrophy (TTD) have defective DNA excision repa…
Lenakap : This multicenter, non randomized (single arm), open, phase II study aims to evaluated the efficacy of Lenalidomide in HIV-associated kaposi disease. P…
This phase Ib trial investigates the side effects of the combination of nivolumab and ipilimumab, and to see how well they work in treating patients with cancer…